JP Morgan Maintains Overweight on Medtronic, Raises Price Target to $128

JP Morgan maintains Medtronic (NYSE:MDT) with a Overweight and raises the price target from $122 to $128.

Benzinga · 12/20/2019 14:38

JP Morgan maintains Medtronic (NYSE:MDT) with a Overweight and raises the price target from $122 to $128.